SINCLAIR PHARMACEUTICALS LIMITED
Patent Owner
Stats
- 9 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 19, 2017 most recent publication
Details
- 9 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 58 Total Citation Count
- Feb 21, 2002 Earliest Filing
- 15 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0215,704 METHODS AND PRODUCTS FOR IMPROVING WOUND HEALINGAbandonedJul 22, 08Aug 26, 10[A61K, A61F]
2010/0003,354 Linseed Extract Medicament for Application to the EyeAbandonedJul 27, 07Jan 07, 10[A61K, A61P]
2008/0269,222 Use of Delmopinol in the Treatment of AcneAbandonedJul 24, 06Oct 30, 08[A61K, A61P, A61Q]
2008/0114,057 COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE MUCOSAE, SKIN AND THE EYEAbandonedJan 11, 08May 15, 08[A61K]
2008/0015,155 Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the EyeAbandonedAug 20, 07Jan 17, 08[A61K]
2007/0213,381 Topical Compositions Comprising Telmesteine for Treating Dermatological DisordersAbandonedOct 07, 04Sep 13, 07[A61K, A61P]
2006/0247,183 Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eyeAbandonedFeb 21, 06Nov 02, 06[A61K]
2004/0254,143 Compositions and methods for the treatment or prevention of inflammationAbandonedJul 15, 04Dec 16, 04[A61K]
2002/0173,485 Compositions and methods for the treatment or prevention of inflammationAbandonedFeb 21, 02Nov 21, 02[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
